Patents by Inventor Sanku Malik

Sanku Malik has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Functionalized nanoceria composition for ophthalmic treatment
    Patent number: 8795737
    Abstract: The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma.
    Type: Grant
    Filed: December 21, 2012
    Date of Patent: August 5, 2014
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Sudipta Seal, Swanand D. Patil, Manas K. Haldar, Sanku Malik
  • FUNCTIONALIZED NANOCERIA COMPOSITION FOR OPHTHALMIC TREATMENT
    Publication number: 20130123515
    Abstract: The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma.
    Type: Application
    Filed: December 21, 2012
    Publication date: May 16, 2013
    Inventors: SUDIPTA SEAL, SWANAND D. PATIL, MANAS K. HALDAR, SANKU MALIK
  • Functionalized nanoceria composition for ophthalmic treatment
    Patent number: 8337898
    Abstract: The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma.
    Type: Grant
    Filed: June 7, 2011
    Date of Patent: December 25, 2012
    Assignee: University of Central Florida Research Foundation, Inc.
    Inventors: Sudipta Seal, Swanand D. Patil, Manas K. Haldar, Sanku Malik
  • FUNCTIONALIZED NANOCERIA COMPOSITION FOR OPHTHALMIC TREATMENT
    Publication number: 20110268662
    Abstract: The invention provides a composition comprising a plurality of nanoceria particles, a sufficient amount of at least one inhibitor of human carbonic anhydrase II associated with said plurality of nanoceria particles, and a pharmaceutically acceptable carrier containing said plurality of nanoceria particles with associated inhibitor. One preferred inhibitor of human carbonic anhydrase II comprises 4-carboxybenzene sulfonamide. The disclosed composition is useful in treatment of glaucoma.
    Type: Application
    Filed: June 7, 2011
    Publication date: November 3, 2011
    Inventors: SUDIPTA SEAL, SWANAND D. PATIL, MANAS K. HALDAR, SANKU MALIK